N--Alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine(5-S-GAD), an antibacterial substance isolated from flesh fly, has been described as having multipotential biological activities toward various tissues. However, there has been no report testing its action on neural cells. In the present study, we investigate whether 5-S-GAD is neurotoxic or neuroprotective to the rat retina. 5-S-GAD at high doses (more than 200 pmol) induced apoptosis of retinal neurons 7 days after intraocular injection. NMDA (50-100 nmol)
Introduction
N--Alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine (5-S-GAD) was isolated from adult flesh fly as a defense protein produced in response to bacterial injection or body injury (Leem et al. 1996) . 5-S-GAD was found to inhibit tyrosine phosphorylation of protein tyrosine kinases (Leem et al. 1998) . Among the protein tyrosine kinases are receptors for growth factors, hormones and viral oncogene products such as v-Src or v-BCR-ABL. This inhibition of tyrosine phosphorylation by 5-S-GAD leads to suppression of tumor cells. 5-S-GAD inhibits cell growth of some human tumor cells in vitro (Akiyama et al. 2000) and in vivo angiogenesis of mouse S180 sarcoma cells (Nishikawa et al. 2006) .
The optimal concentration of 5-S-GAD for the inhibition of cell growth is relatively high, in the order of 10-100 M. Although the biological activity of 5-S-GAD has been examined in a variety of cellular systems, its action on nervous system is totally unknown. Therefore, in the present study, we tested how 5-S-GAD affects control retina and retina treated with excessive amounts of the glutamate receptor subtype agonist, (NMDA or optic nerve injury.
Excitotoxicity induced by NMDA and delayed cell death by optic nerve injury are thought to be an experimental model for retinal ischemia and glaucoma (Lafuente et al. 2001) . The toxic effect of 5-S-GAD was examined in the control retina at doses of 2-2000 pmol. The protective effect of 5-S-GAD was examined in the NMDA treated or optic nerve injured retina at doses of 2-20 pmol. 5-S-GAD at high doses (200-2000 pmol) was certainly apoptotic to retinal cells, particularly retinal ganglion cells (RGCs), while 5-S-GAD at low doses (2-20 pmol) was oppositely protective against the NMDA-or optic nerve crush-induced cell damage to RGCs. Such a hormesis-like action of 5-S-GAD is described here for the first time.
Furthermore, we sought the signaling cascade(s) operative in the 5-S-GAD-mediated neuroprotection of RGCs, with particular focus on cell survival pathways and glial activation.
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Results
< ----- Fig. 1 
Induction of apoptosis in the rat retina by 5-S-GAD at high doses
When 5-S-GAD (2-2000 pmol) was injected into rat eye, no terminal transferase dUTP nick end labeling (TUNEL) -positive cells could be seen in the retina until 5 days after injection (data not shown). However, a small number of TUNEL-positive RGCs appeared 7 days after injection of 5-S-GAD (more than 200 pmol, Fig. 1D ). 5-S-GAD (2000 pmol) induced apoptosis of almost all retinal neurons, including those in the outer nuclear, inner nuclear and ganglion cell layers (Fig. 1E) . No effect could be seen at low doses (2-20 pmol)
of 5-S-GAD (Fig. 1B , 2 pmol; C, 20 pmol), like PBS treatment (Fig. 1A ).
< ----- Fig. 2 
Prevention of NMDA-induced apoptosis in the retina by 5-S-GAD at low doses
When NMDA (2-100 nmol) was injected into rat eye, concentrations of more than 20 nmol significantly induced apoptosis of retinal cells in the inner nuclear layer and ganglion cell layer neurons within 72h after injection (Fig. 2B , 50 nmol; 2C, 100 nmol). However, to observe the maximum prevention effect of 5-S-GAD, we studied TUNEL assay at 7 days after injection. Interestingly, the apoptosis of retinal neurons induced by 100 nmol NMDA 7 days after injection was significantly reduced by treatment with 2-20 pmol 5-S-GAD (Fig. 2D, 20 pmol). Such a dose of 5-S-GAD alone did not induce any apoptosis of retinal cells (see Fig.   1C ), as in the control ( Fig. 2A) . We qualitatively confirmed that most of apoptotic cells in the ganglion cell layer were RGCs using an immunohistochemial study with anti--tublinIII (Koriyama unpublished data)
< ----- Fig. 3 2.3. 5-S-GAD protects against the NMDA-induced loss of RGCs and thinning of the inner retina NMDA (100 nmol) induced RGC apoptosis 7 days after injection (Fig. 2) . We next examined actual loss of RGCs in the rat retina with HE staining. RGCs were certainly lost 7 days after NMDA injection (Fig. 3B ) as compared with PBS treatment (Fig. 3A) . 5-S-GAD (2-20 pmol) prevented the cell loss induced by NMDA (Fig. 3C) . Graphical quantification of cell loss induced by NMDA with or without 5-S-GAD is shown in Fig. 3D . Thinning of the inner retina (marked with a vertical line in each figure) 7 days after NMDA treatment was additionally notable in comparison with controls (cf. Fig. 3A and 3B ). The thinning of the inner retina by NMDA was also prevented by prior injection of 2-20 pmol of 5-S-GAD ( Fig.   3C , E). 5-S-GAD (2-20 pmol) significantly blocked the loss of RGCs and the thinning of the inner retina induced by NMDA. The thickness of the outer nuclear layer was not changed by NMDA treatment (Koriyama, unpublished data).
< -----Figs 4 & 5
5-S-GAD activates cell survival signals in the rat retina
We next examined the cell survival system responsible for the neuroprotective action of 5-S-GAD (2-20 pmol), specifically by analyzing the levels of two representative cell survival molecules, phospho-Akt and Bcl-2, in the rat retina (Homma et al. 2007) . In control retina, weak immunoreactivity of phopho-Akt could be seen in the bipolar cells and ganglion cells (Fig. 4A) . 5-S-GAD rapidly increased phospho-Akt expression in the retina 1 day after injection. This increase in the level of phospho-Akt continued until at least 7 days after injection. The cellular localization of this increase was in both ganglion cells and bipolar cells, as detected with anti-phospho Akt antibody (Fig. 4B) . The phospho-Akt activity in bipolar cells was confirmed by double staining for protein kinase C (PKC) (Negishi et al. 1988 ). The immunopositive reactivity of bipolar and ganglion cells induced by 5-S-GAD was unchanged under NMDA treatment (Fig. 4D) . No positive signals for phospho-Akt were seen in the NMDA-treated retina (Fig. 4C) . We further examined Bcl-2 expression after 5-S-GAD injection. In control retina, no significant immunoreactivity for Bcl-2 could be seen (Fig. 5A ). 5-S-GAD at low doses (2-20 pmol) increased Bcl-2 expression in the rat retina 3 days after injection and this increase in the level of Bcl-2 continued until at least 7 days after injection. The cellular localization of this increase was also observed in both ganglion cells and bipolar cells with anti-Bcl-2 antibody (Fig. 5B ). The increase in the level of Bcl-2 in RGCs induced by 5-S-GAD was unchanged by NMDA treatment (Fig. 5D ). No positive staining for Bcl-2 was seen in the NMDA-treated retina (Fig. 5C ).
< ----- next measured the levels of these survival molecules by Western blotting analysis. 5-S-GAD alone increased phospho-Akt protein levels 2-fold in the retina 7 days after injection as compared with the control value (Fig. 6A) . Conversely, NMDA alone reduced the levels of phospho-Akt by 40% of control in the retina 7 days after injection. The reduced levels of phospho-Akt induced by NMDA treatment was almost recovered by 5-S-GAD (Fig. 6A ).
5-S-GAD also increased Bcl-2 levels 1.6 fold in the retina 7 days after injection (Fig. 6B ).
NMDA alone decreased the levels of Bcl-2 in the retina 7 days after treatment by 40% of control value. The reduced levels of Bcl-2 induced by NMDA treatment was recovered by 5-S-GAD (Fig. 6B ).
< ----- Fig. 7 
5-S-GAD does not affect glial activation induced by NMDA treatment
To investigate the neuroprotective mechanism of 5-S-GAD against NMDA excitotoxicity, we studied the effect of 5-S-GAD on glial activation (Honjo et al. 2000) . < ----- Fig. 8 
5-S-GAD-
5-S-GAD prevents apoptosis of RGCs after optic nerve crush
Optic nerve crush retrogradely induces cell death of RGCs in the rat retina 6-7 days after injury (Homma et al. 2007) . As shown in Fig. 8C , many RGCs in the rat retina became TUNEL positive 7 days after optic nerve injury ( The expression levels of the cell survival molecules phospho-Akt and Bcl-2 were enhanced 1-3 or 3-5 days after injection, respectively. The neuroprotective effect of 5-S-GAD was examined under the condition of NMDA excitotoxicity. It is currently accepted that most damaged cells (>70%) by NMDA are RGCs in ganglion cell layer (Siliprandi et al., 1992) . kinase/Akt system in rat RGCs, via either brain-derived neurotrophic factor or insulin-like growth factor-I (Mansoar-Robay et al. 1994; Kermer et al. 2000; Homma et al. 2007) ; (3) 5-S-GAD inhibits Src protein kinase leading to protection against NMDA excitotoxicity, as shown in hippocampal or striatal neurons after ischemic insult (Hou et al. 2007; Crossthwaite et al. 2004) . Through which possibilities 5-S-GAD is neuroprotective to the RGCs, is uncertain at present. Anyhow, such hormesis like action of 5-S-GAD on the nervous cell system is enough considerable.
Neuroprotective action of 5-S-GAD on glaucomatous conditions in the rat retina in vivo
Glaucoma is an optic nerve neuropathy caused by a complicated etiology including an increase in intraocular pressure, ocular hypertension, optic disc ischemia and oxidative stresses (Weinreb and Levin, 1999; Kuehn et al. 2005) . Progression of optic nerve degeneration finally results in cell death of RGCs and loss of vision. The main therapeutic target for treating glaucoma is decreasing intraocular pressure (Bakalash et al. 2002 ). An anti-glaucoma drug with neuroprotective or neuroregenerative properties has been awaited for a long time. In this study, 5-S-GAD (2-20 pmol) clearly prevented RGCs from undergoing cell death induced by NMDA and optic nerve injury. These two models of RGCs damage are often used as glaucomatous conditions (Tezel and Wax, 1999) . The pathophysiology of NMDA exposure is simulated to be equivalent to ischemia, calcium overload, generation of super oxide or nitric oxide radicals (Lipton et al. 1994) . It is also well known that optic nerve injury retrogradely induces apoptosis of RGCs 6-7 days after injury (Berkelaar et al. 1994) . Interestingly, expression of phospho-Akt was rapidly downregulated in rat RGCs 1 day after optic nerve crush (Homma et al. 2007 ). Since 5-S-GAD first activates phospho-Akt in the retina at 1-3 days (Fig. 4) followed by expression of Bcl-2 3-5 days after injection (Fig. 5) , the activation of phospho-Akt plays a key role in the neuroprotection induced by 5-S-GAD. The neuroprotective effect of 5-S-GAD is directly mediated through the phophos-Akt/Bcl-2 systems, but is not mediated by glial activation (Fig. 7) . It is well known that phospho-Akt increases synthesis of Bcl-2 protein via phosphorylation of cAMP response element binding protein (Pugazhenthi et al. 2000) . Moreover, another cell survival factor, mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) was not activated by 5-S-GAD (data not shown). Of course, further studies using other types of glaucoma model, such as increasing intraocular pressure (Wang et al. 2005) , are needed. Taken together, these data strongly indicate that this small peptide from flesh fly might become an epoch-making neuroprotective or neuroregenerative reagent against glaucomatous conditions.
In conclusion, 2-20 pmol (corresponding to 0.01-0.1 M in the ocular fluid) of 5-S-GAD clearly protected the RGCs in rat retinas from cell death induced by exitotoxic NMDA or optic nerve injury in vivo. The neuroprotective mechanism is thought to involve activation of the cell survival phospho-Akt/Bcl-2 system. Although the exact pathway leading to activation of this cell survival system is not yet clarified, these results strongly indicate that this novel action of 5-S-GAD might become a therapeutic option for rescuing damaged RGCs in glaucoma patients.
Experimental procedures
Animals and surgery
Sprague-Dawley rats (body weights 250-300 g) were used throughout the study. Rats were reared and handled according to NIH guidelines and the ARVO statement on the care and use of laboratory animals. Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (30-40 mg/kg body weight). Various concentrations of NMDA or 5-S-GAD were injected intravitreally in a 5-l solution with a micro-syringe. The optic nerve was crushed 1 mm away from the eyeball with forceps, as described elsewhere (Homma et al.
2007
). Rats were reared in clear plastic cages and kept under a 12 h/12 h light-dark cycle at 23˚C.
Morphological measurement of surviving RGCs in rats after NMDA and/or
5-S-GAD treatment
Fixation and cryosection of retinal samples have been described elsewhere (Homma et al., 2007) . In brief, rat eyes were enucleated and fixed in 0.1 M phosphate buffer (pH 7.4) containing 4% paraformaldehyde and 5% sucrose for 2 h at room temperature, followed by incubation in 20% sucrose overnight at 4˚C. All eyes were then embedded into OCT compound in vinyl molds, and frozen in liquid nitrogen. Retinal sections in central areas within 300-m were cut at 12-m thickness, and mounted onto silane-coated slides. To evaluate surviving RGCs after treatment, we performed immunohistochemistry using anti--tublinIII antibody (TUJ1, R & D Systems, Minneapolis, USA) and HE staining. The number of surviving RGCs was performed by counting the cells with more than 10 m in diameter to avoid miscounting the displaced amacrine cells under microscopic observation of 25 visual fields per retina (Sabel et al. 1995) . The thickness of the inner retina (outer plexiform layer, inner nuclear layer, inner plexiform layer and ganglion cell layer) was calculated from transverse sections.
TUNEL staining
After fixation and cryosection, retinal tissues were incubated in 0.1% Triton X-100 and 
Immunohistochemistry
Immunohistochemical staining of cell survival molecules (phospho-Akt and Bcl-2) and retinal cell markers, including PKC for bipolar cells, GFAP for Müller cells, and -tublin III for ganglion cells, has been described elsewhere (Koriyama et al. 2007) . The primary antibodies used were anti-mouse Bcl-2 (1:200), anti-mouse PKC (1:200) were purchased from Santa Cruz. Anti-mouse phospho-Akt (1:500) and anti-mouse GFAP antibody (1:100) were purchased from Sigma-Aldrich, USA. Following washing and blocking, tissue sections were incubated with primary antibodies overnight at 4˚C. After washing, retinal sections were incubated with an Alexa Fluor 488 secondary antibody (Molecular Probe, Japan) for visualization at room temperature.
Western blotting analysis of cell death and survival signals
Retinal extracts were prepared at 7 days after treatment. Retinas were immersed in Tris-HCl buffer (pH 7.4) containing a protease inhibitor cocktail (Sigma), and were then sonicated and centrifuged for 10 min at 1,000 g, as described previously (Koriyama et al., 2003) . Following SDS-PAGE electrophoresis in 12.5% gel, proteins were transferred onto a nitrocellulose membrane (Amersham International, U.K.). The membrane was incubated in a blocking buffer (3% bovine serum albumin in PBS) for 1 h at room temperature, and probed with a primary antibody in blocking buffer overnight at 4˚C. The membrane was further washed, and probed with a secondary antibody in blocking buffer for 1 h at room temperature, and washed again. The signal (56 kDa of p-Akt and 26 kDa band of Bcl-2 protein) was detected using 3, 3'-diaminobenzidine tetrahydrochloride. The same primary antibodies in immunohistochemical study were used. An appropriate anti-IgG antibody (Santa Cruz Biotechnology, CA) was used as secondary antibody (1:200-1,000). To comfirm the amount of protein on acrylamide gel, we performed staining for protein by rapid stain Coomasie brilliant blue kit (Nacalai Tesque, Kyoto). Each protein band was densitometrically analyzed by the NIH imaging software (NIH, Bethesda, MD, USA). All experiments were repeated at least 3 times.
Statistics
Values of surviving or apoptotic RGCs, retinal thicknesses and density of the band in Western blotting are indicated as means±S.E.M for 3 experiments. Statistical significance was determined as P<0.05 using one way ANOVA followed by the Bonferroni test. unlike the control (A). 5-S-GAD (2 nmol) induced apoptosis of almost all retinal neurons including outer nuclear, inner nuclear and ganglion cell layers 7 days after injection (E).
Scale bar=50 m. 
